Pentoxifylline

This classification denotes a phosphodiesterase inhibitor and antiplatelet agent and alkaloid with the molecular formula C13H18N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SD6QCT3TSU, chemically known as 1,2,3,6-tetrahydro-3,7-dimethyl-1-(5-oxohexyl)-2,6-purindion but generally known as pentoxifylline, which bears US NIH Compound Identifier 4740. European Medicines Agency schedules Pentoxifylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09705MIG. The term PENTOXIFYLLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, No. 10 1973, List 13). World Health Organization schedules pentoxifylline in its Anatomical Therapeutic Chemical (ATC) Classification. PENTOXIFYLLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pentoxifylline under HS 29395900 and SITC 54145. As of Q4 2014, PENTOXIFYLLINE remains the US FDA Preferred Term for this commodity. Pentoxifylline bears US NLM identifiers UMLS ID C0030899 and NCI Concept Code C733. SMILES: CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C.